Home » Topics » BioWorld Science

BioWorld Science
RSS

Softer touch enhances drug delivery efficiency

May 24, 2019

FDA lifts target class clinical hold for lanifibranor

May 24, 2019

Modulation of PIK3C2B improves vaccination against influenza in PHIV children

May 24, 2019

Quinolinone SRI-34329 inhibits Venezuelan equine encephalitis virus at micromolar concentrations

May 24, 2019

APRINOIA Therapeutics awarded Michael J. Fox Foundation grant for Parkinson's research

May 24, 2019

Argenx expands pipeline with ARGX-117 and ARGX-118

May 24, 2019

New phase II HopES study to investigate SM-88 in high-risk sarcomas

May 24, 2019

Oral antisense-miRNA-214 as a possible treatment for colitis

May 24, 2019

Compass opens first-in-human study of CTX-471 in malignancies that progress on PD-1/PD-L1 inhibitors

May 24, 2019

Phase III ClarIDHy study of Tibsovo in cholangiocarcinoma meets primary endpoint

May 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...